Publication Abstract Display | Type: Published Manuscript | Title: Characterizing HIV medication adherence for virologic successes among individuals
living with HIV/AIDS: Lessons from the CNS HIV Antiretroviral Therapy Effects Research. | Authors: Biswas B, Spitznagel E, Collier A, Gelman B, McArthur J, Morgello S, McCutchan JA, Clifford DB
and the CHARTER Group | Year: 2014 | Publication: Journal of HIV/AIDS & Social Services | Volume: 13 Issue: 1 Pages: 8-25 | Abstract:Antiretroviral therapy (ART) has changed infection with HIV from a terminal illness to a
chronic disease by suppressing viral load to undetectable levels. Success with ART is dependent
on optimal adherence to a strict regimen, widely accepted at >95%. As medication type, class
and frequency of use continue to evolve, we assessed adherence levels related to viral
suppression. Using a cross-sectional analysis with secondary data (n = 381) from an ongoing
multi-site study on impact of ART on the Central Nervous System (CNS), we compared selfreported
adherence rates with biological outcomes of HIV-RNA copies/ml, and CD4 cell/ mm3.
Adherence to ART measures included taking all prescribed medication as directed on schedule
and following dietary restrictions. While depression was a barrier to adherence, undetectable
viral suppression was achieved at pill adherence percentages lower than 95%. Practice, research
and policy implications are discussed in the context of patient-, provider-, and system-level
factors influencing adherence to ART. |
return to publications listing
|